2025-01-17 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**1. Performance Comparison and Divergence:**

Intuitive Surgical Inc. (ISRG) is a company that develops and manufactures surgical robots.  Over the given period, ISRG significantly outperformed the S&P 500 (VOO). The cumulative return for ISRG is 322.29%, while VOO's is 116.43%.  The difference in cumulative returns is approximately 205.9%, placing it at the 99.7th percentile of its historical range relative to the S&P 500.  This indicates a substantial outperformance.  The provided alpha values of 0.0 across all years suggest that this outperformance isn't solely explained by systematic market risk, hinting at other factors driving ISRG's returns.  However,  it's crucial to note that the alpha calculation relies on the model used and might not capture all market influences.

**2. Recent Price Movement:**

* **Closing Price:** $579.02
* **Last Market Price:** $583.48
* **5-Day Moving Average:** $557.05
* **20-Day Moving Average:** $538.48
* **60-Day Moving Average:** $533.60

The last market price ($583.48) is slightly above the closing price, suggesting a minor upward trend in the very short term. The price is significantly above all three moving averages, indicating a potential upward momentum.  However, the difference between the closing price and the last market price is minor and requires further observation to confirm a significant trend.

**3. Technical Indicators and Expected Return:**

* **RSI:** 68.09 –  Suggests the stock is in overbought territory, potentially indicating a short-term pullback is possible.
* **PPO:** 0.84 –  A positive PPO value suggests bullish momentum.
* **Recent Relative Strength Change (20-day):** +3.4% – Indicates a short-term upward trend in relative strength.
* **Expected Return (2+ years):** 16.7% – This represents the anticipated outperformance relative to the S&P 500 over the long term through consistent investment.  A higher last market price of $583.48 compared to the closing price doesn't represent a drastic change and doesn't suggest immediate 급반등 (sharp rebound) or 급하락 (sharp decline).

**4. Recent Earnings Analysis:**

| Date       | EPS     | Revenue      |
|------------|---------|-------------|
| 2024-10-18 | $1.59   | $2.04B      |
| 2024-07-19 | $1.48   | $2.01B      |
| 2024-04-19 | $1.54   | $1.89B      |
| 2023-10-20 | $1.18   | $1.74B      |
| 2024-10-18 | $1.18   | $1.74B       | *(Duplicate Entry - likely a data error)*


There appears to be a duplicate entry for October 18th, 2024.  Ignoring the duplicate,  revenue shows a generally upward trend, while EPS fluctuates but remains relatively stable.  Further analysis is needed to fully understand the underlying drivers of this performance and address the data inconsistency.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-09-30 | $2.04B  | 67.41%        |
| 2024-06-30 | $2.01B  | 68.30%        |
| 2024-03-31 | $1.89B  | 65.87%        |
| 2023-12-31 | $1.93B  | 66.24%        |
| 2023-09-30 | $1.74B  | 66.94%        |

Revenue is generally increasing, and profit margins are consistently high and stable, demonstrating strong profitability.

**Capital and Profitability:**

| Quarter | Equity    | ROE     |
|---------|-----------|---------|
| 2024-09-30 | $15.58B  | 3.63%   |
| 2024-06-30 | $14.71B  | 3.58%   |
| 2024-03-31 | $13.96B  | 3.90%   |
| 2023-12-31 | $13.31B  | 4.56%   |
| 2023-09-30 | $12.54B  | 3.32%   |

Equity is growing, although ROE fluctuates.  The relatively stable ROE indicates consistent profitability relative to shareholder equity.

**7. Overall Analysis:**

ISRG shows strong historical performance, significantly outperforming the S&P 500.  Recent price movements suggest upward momentum, although RSI indicates potential short-term overbought conditions.  Financial statements reveal strong revenue growth and consistently high profit margins. However, there are data inconsistencies that need clarification (duplicate earnings data).  The high expected return warrants further investigation to understand the drivers of this expected outperformance.  Investors should consider the potential for short-term price corrections due to the overbought RSI while maintaining a long-term perspective given the strong fundamentals and historical performance.  Further due diligence is recommended before making any investment decisions.  The alpha of 0 warrants further investigation into the model used and potential sources of outperformance.
